ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action

Liang, Rui; Yang, Xiang-Na; Lin, Shan; Yi, Wei-Qing; Chen, Xiao-Gang; Dong, Xin; Guo, Long-Gang; Li, Yan-Kun; Zhao, Yue-Rui; Xu, Hua*广州中医药大学; 1
Annals of Translational Medicine2022-6DOI: 10.21037/atm-22-1962
1被引8阅读
引用收藏
分享

摘要

Background: Chuankezhi injection (CKZ) is a Traditional Chinese Medicine (TCM) injection extracted from Chinese herbs Epimedium sagittatum (Yin Yang Huo) and Morinda officinalis (Bai Ji Tian). Studies have shown that CKZ has a positive effect in improving diabetic nephropathy and regulating immune function. Focal segmental glomerulosclerosis (FSGS) is a kind of refractory nephropathy, which has been confirmed as closely associated with immunity. Whether CKZ is effective against FSGS and how it works warrant further study. This study aimed to verify the efficacy of CKZ in rats with steroid-resistant (SR) FSGS and explore its mechanism of action. Methods: We established an SR FSGS model in male Sprague Dawley (SD) rats by injecting adriamycin into the tail vein. Based on group intervention and comparison, the primary efficacy parameters of FSGS were observed, including general condition, 24-hour urine protein, serum albumin, cholesterol, triglyceride, and renal pathological changes. Network pharmacological analysis and molecular docking were used to predict the mechanism of action of CKZ. Finally, we used quantitative polymerase chain rection (qPCR) and western blot (WB) to detect messenger RNA (mRNA) expression and protein phosphorylation at specific targets in rat kidney tissue to validate the predicted results. Results: Intramuscular injection of CKZ had a dose-dependent effect in SR FSGS model rats, including lowering urine protein, increasing serum albumin, lowering cholesterol and triglyceride, and treating pathological lesions in the kidney. Network pharmacological analysis and Molecular docking revealed that 5 active components (Icariin, Icariside II, Epimedin C, Icaritin, and Noricaritin) might be the critical components. The findings also revealed that Akt was perhaps the critical target gene, the PI3K-Akt signaling pathway was perhaps the critical pathway, and reversible protein phosphorylation was probably the critical biological process. The qPCR and WB analyses showed that CKZ significantly increased the relative mRNA expression and protein phosphorylation of PI3K and Akt, respectively. Conclusions: This study showed that intramuscular injection of CKZ has a significant therapeutic effect in SR FSGS rats, which may be associated with the activation of PI3K-Akt signaling by CKZ.

学科与关键词

关键词
Chuankezhi injection (CKZ)focal segmental glomerulosclerosis (FSGS)new indicationmechanism of actionPI3K-Akt signaling
相关
加载中…
  • Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT
    Li, Run; Shi, Chunru; Wei, Cuiting; Wang, Chao; Du, Hongjian; Liu, Ran; Wang, Xu; Hong, Quan*; Chen, Xiangmei*PHYTOMEDICINE, 2023, 116: 154873.被引 1
  • Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation
    Wang, Lijuan; Liu, Huoliang; Wang, Yi; Hong, XiaoFan; Huang, Xiaoyan; Han, Miaoru; Wang, Dan; Shan, Wenjun; Li, Ping; Gu, Haowen; Liu, Bo*; Bao, Kun*Drug Design Development and Therapy, 2023, 17: 1847-1861.
  • Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway
    Chen, Junqi; Yuan, Shengliang; Zhou, Jie; Huang, Xiuye; Wu, Wenjia; Cao, Yiwen; Liu, Hong; Hu, Qinghong; Li, Xiaojie; Guan, Xueping; Yin, Simin; Jiang, Jiaying; Zhou, Yuan*; Zhou, Jiuyao*PHYTOMEDICINE, 2022, 107: 154477.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2022-06
卷期
第 10 卷, 第 11 期
DOI
10.21037/atm-22-1962
期刊等级
4区
成果收录
SCIE
资助标注
Traditional Chinese Medicine Bureau of Guangdong Province [20191118]

作者

  • L

    Liang, Rui (第一作者)

    1 · guangzhou univ chinese med

  • Y

    Yang, Xiang-Na

    guangzhou women & childrens med ctr · 1 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • L

    Lin, Shan

    1 · guangzhou univ chinese med

  • Y

    Yi, Wei-Qing

    1 · guangzhou univ chinese med

  • C

    Chen, Xiao-Gang

    1 · guangzhou univ chinese med

  • D

    Dong, Xin

    guangzhou univ chinese med · 1

  • G

    Guo, Long-Gang

  • L

    Li, Yan-Kun

  • Z

    Zhao, Yue-Rui

  • X

    Xu, Hua (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417